Adoption and Diffusion of Evidence‐Based Addiction Medications in Substance Abuse Treatment

Health Services Research - Tập 49 Số 1 - Trang 127-152 - 2014
Carolyn J. Heinrich1, Grant R. Cummings2
1Lyndon B. Johnson School of Public Affairs and Department of Economics, The University of Texas at Austin, P.O. Box Y, Austin, TX, 78713-8925.
2Wisconsin Legislative Fiscal Bureau Madison WI

Tóm tắt

ObjectiveTo examine the roles of facility‐ and state‐level factors in treatment facilities' adoption and diffusion of pharmaceutical agents used in addiction treatment.Data SourcesSecondary data from the National Survey of Substance Abuse Treatment Services (N‐SSATS), Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Medicare and Medicaid Services, Alcohol Policy Information System, and Kaiser Family Foundation.Study DesignWe estimate ordered logit and multinomial logit models to examine the relationship of state and treatment facility characteristics to the adoption and diffusion of three pharmaceutical agents over 4 years when each was at a different stage of adoption or diffusion.Data CollectionN‐SSATS data with facility codes, obtained directly from SAMHSA, were linked by state identifiers to the other publicly available, secondary data.Principal FindingsThe analysis confirms the importance of awareness and exposure to the adoption behavior of others, dissemination of information about the feasibility and effectiveness of innovations, geographical clustering, and licensing and accreditation in legitimizing facilities' adoption and continued use of pharmacotherapies in addiction treatment.ConclusionsPolicy and administrative levers exist to increase the availability of pharmaceutical technologies and their continued use by substance abuse treatment facilities.

Từ khóa


Tài liệu tham khảo

Backer T. E., 1995, Reviewing the Behavioral Science Knowledge Base on Technology Transfer (NIDA Research Monograph 155, NIH Publication No. 95 – 4035), 169

10.2307/1963526

10.2307/2111588

Borins S., 1998, Innovating with Integrity: How Local Heroes Are Transforming American Government

10.1016/S0740-5472(02)00228-3

10.2307/256406

10.1176/appi.ps.52.4.469

10.1016/j.jsat.2006.05.021

10.1016/S0740-5472(98)00018-X

10.1016/j.jsat.2005.02.003

10.1176/appi.ps.52.12.1591

10.1300/J069v23n04_02

10.1002/pam.10178

10.1111/j.1475-6773.2007.00812.x

10.1081/ADA-120015871

10.1093/jopart/mug033

10.1016/j.jsat.2006.03.013

10.1016/S0740-5472(03)00158-2

10.1097/ADM.0b013e318262a97a

10.1016/j.jsat.2005.05.002

10.1177/002204260503500308

10.1016/j.jsat.2006.08.003

10.1177/106591290105400106

10.15288/jsad.2007.68.852

10.1080/02791072.2010.10400546

Rogers E. M., 2003, Diffusion of Innovations

10.1016/j.jsat.2006.06.017

10.1016/S0740-5472(02)00241-6

10.1007/978-1-4899-1742-3_20

10.15288/jsad.2012.73.413

10.1016/S0740-5472(02)00231-3

10.1016/j.jsat.2006.12.022

Thomas C. P., 2004, New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions, 140

10.2307/1954434

10.1023/A:1021357318246

Yi H., 2007, Effect of Health Insurance Parity Laws on Healthcare Coverage for Alcohol‐Related Hospitalizations in the United States

10.1016/0740-5472(95)02012-8